Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Angela Ramos-Montoya
Observed names:
A Ramos-Montoya,
A. Ramos-Montoya
Institutions:
Hospital General Universitario de Alicante Doctor Balmis,
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL)
Observed institutions:
Hospital General Universitario de Alicante Doctor Balmis,
Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL)
ORCID:
0000-0001-9247-3427
Observed ORCID:
0000-0001-9247-3427
OpenAlex ID:
A5113854757
942 The androgen receptor induces a distinct transcriptional program in castration resistant prostate cancer in man
2012
·
N.L. Sharma
, C.E. Massie
, et al.
·
European Urology Supplements
·
11
High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype
2024
·
Yoel G. Montoyo-Pujol
, José J. Ponce
, et al.
·
Cancer Cell International
·
5
PDF
Plan de cuidados tras cirugía conservadora en mujer con cáncer de mama: A propósito de un caso
2019
·
A Ramos-Montoya
, M Segura-Martín
, et al.
·
Revista ROL de enfermería
·
3
C-MYC induction of HES6 activates a distinct transcriptional network driving androgen insensitive prostate cancer
2011
·
April Lamb
, A. Ramos-Montoya
, et al.
·
British journal of surgery
·
1
A systemic immune signature stratifies early-stage breast cancer patients and reveals soluble IL-2RA and PD-1 as potential independent prognostic biomarkers
2026
·
Yoel G. Montoyo-Pujol
, Pascual Martínez-Peinado
, et al.
·
Breast Cancer Research
203 Reduction of PR and Ki67 Expression after Perioperative Hormonal Treatment in Luminal Breast Carcinoma is Time-Dependent
2025
·
Lucía Martínez Gauffin
, Yoel G. Montoyo-Pujol
, et al.
·
Laboratory Investigation
EP-2298: Hypoxia inducible factor 1α confers androgen independence in prostate cancer
2018
·
B. Bibby
, M. Tran
, et al.
·
Radiotherapy and Oncology
Hypoxia inducible factor 1 alpha confers androgen independence in prostate cancer
2018
·
B. Bibby
, Mai Tran
, et al.
·
Radiotherapy and Oncology
283 Similar expression to FGF (Sef) is an important determinant of the prostate cancer cells' ability to metastasise in vivo
2015
·
S. Hori
, K. Wadhwa
, et al.
·
European Urology Supplements
836 Hes6 drives a critical androgen receptor (AR) transcriptional program to induce castration resistant prostate cancer (CRPC) through activation of an E2F1-mediated cell cycle network
2014
·
A.D. Lamb
, A. Ramos-Montoya
, et al.
·
European Urology Supplements
833 Monitoring the effects of therapeutic fatty acid synthase inhibition in prostate canecr using 11C acetate PET
2013
·
G.L. Shaw
, D. Lewis
, et al.
·
European Urology Supplements
935 Activation of HIF1α promotes androgen independent prostate cancer cell growth
2013
·
M. Tran
, F. Lo
, et al.
·
European Urology Supplements
823 Transcriptional down-regulation of the androgen receptor by promoter G-quadruplex stabilisation; a potential alternative treatment in castrate-resistant prostate cancer
2013
·
T.J. Mitchell
, A. Ramos-Montoya
, et al.
·
European Urology Supplements
Investigating the role for c-myc and bHLH transcription factors in driving phenotypic versatility of cancer stem cells in castrate resistant prostate cancer
2010
·
April Lamb
, A. Ramos-Montoya
, et al.
Show more works
View as search
Works count:
14
Citation count:
20
H-index:
3
I10-index:
1
Year
Topic
Type